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EXPERIMENTS involving direct application of the large dose of 0 5 Illg. of 9:10-
dimethyl-1:2-benzanthracene into the lungs of mice of strain Street formed a
part of a comprehensive study (Rask-Nielsen, 1948) carried out in an endeavour
to confirin or repudiate the hypothesis that tumours can be induced only in tissues
that produce tumours spontaneously, whereas tissues that do not produce
tumours spontaneously are unable to develop tumours even following very power-
ful carcinogenic action. The experiments showed that direct application of
0-5 mg. of 9:10-dimethyl-1:2-benzanthracene to mice of the strain used induced
specific tumours of the spontaneously tumour-producing tissues, thynmus, lung
and subcutaneous tissue, but failed to affect the mammary tissue which also
develops spontaneous tumours. With the exception of one testicular tumour,
specific tumours were not induced in the spleen and lymph nodes, tissues which
were presumed to develop no spontaneous tumours, or in kidney and testes,
tissues known to produce no spontaneous tumours. Moreover, non-specific
tumaours, in the form of spindle-cell sarcomas, were observed only in experiments
where they could have originated in the subcutaneous tissue and not in those
where they would have to be derived from the interstitial connective tissue of the
organ. Thus, direct application of 9:10-dimethyl-1:2-benzanthracene, 0.5 mg.,
to the lung, kidney and spleen did not induce spindle-cell sarcomas in these organs.
Attempts were then made to ascertain whether and to what extent other
carcinogenic hydrocarbons, under the same experimental conditions, would induce
specific tumours in some of the organs studied, including the lung, and whether
such hydrocarbons, unlike 9:10-dimethyl-1:2-benzanthracene, would be able to
induce non-specific spindle-cell sarcomas in thelung. To this end, 3:4-benzpyrene,
1:2:5:6 dibenzanthracene, or 20-methylcholanthrene, all in doses of 0 5 mg., were
introduced directly into the lungs of Street mice.
Since application of 9:10-dimethyl-1:2-benzanthracene to the lung had pre-
viously induced thymic tumours (Rask-Nielsen, 1948), the present experiments
were presumed to afford information also about the tumours which the three
hydrocarbons would be capable of inducing in the thymus.
These experiments will be reported in the present paper, which also includes
the previous experiments with 9:10-dimethyl-1:2-benzanthracene for comparison.
MATERIAL AND METHODS.
Benzpyrene, dibenzanthracene, or methylcholanthrene, 0 5 mg., was injected,
suspended in 0 01 c.c. of the same mixture of hard and liquid paraffin as used in118 R. RASK-NIELSEN
the previous experiments (Rask-Nielsen, 1948). The technique was as follows:
In order to make the path ofthe needle in the lung tissue as long as possible, the
needle- was inserted through the abdominal wall, immediately below the right
costal border, and plunged through the diaphragm and longitudinally upwards
through about two-thirds ofthe chest, before the suspension was injected.
The mice used were litter mates ofstrain Street, aged 5 to 7 weeks, divided into
four lots. One lot was left untreated as controls, whereas the other three were
injected with the respective hydrocarbons. As far as possible, the litters were
divided equally in all four lots, an equal number of males and females in each
lot. In the corresponding experiments carried out with 9:10-dimethyl-1:2-
benzanthracene (Rask-Nielsen, 1948) litters of Street mice were divided into lots
ofequal number, one of which was set aside as a control group. The only spon-
taneous tumours observed among all the controls were two cases of pulmonary
adenoma in mice aged 12 and 19 months, and six cases of mammary carcinoma
in mice aged 13 to 22 months.
The mice were fed whole wheat and rolled oats with a weekly addition of cod
liver oil and yeast. All dead mice were autopsied, and all grossly visible pul-
monary and thymic growths were examined microscopically.
RESULTS.
Table I sets out the number and survival time of the experimental mice. It
will be seen that only a few mice reached an advanced age. The high mortality
TABLE I.-Number and Survival Time of the Experimental Mice.
Months.
Injection of 0-5 mg.
3. 6. 9. 12. 15. 18. 21. 24.
Benzpyrene. . . . .85 .71 .29 .20 .17 .7 .2 .0
Dibenzanthracene. . . .79 .45. 8. 6. 1. 0
Methylcholanthrene . . . 77 . 34 . 6 . 2 . 1 . 0
9:10-Dimethyl-1:2-benzanthracene . 83 . 23 . 6 . 3 . 0 . -
was due partly to the induced growths, but partly also to the development of
hydrothorax so severe that the lifetime of the mice was greatly reduced, even in
the absence of tumours.
The growths observed are presented in Table II, which shows that thymic
tumours were observed in addition to adenomas and spindle-cell sarcomas of the
lung.
TABLE II.-Incidence of Tunmors.
Pulmonary tumours.
Adenomas in the right lung.
,- i- m Spindle-cell sarcomas. Thymic tumours. Injection of 0-5 mg. Macroscopic. Microscopic.
Number Ae Number
of oon Of Age in Incidence. Age in Incidence. Age in
tumours. months. tumours. months. months. months.
Benpyrene . . 2/20 . 15, 17 . 0/6 . - 2/81, 2.5% . 7-8 . 4/85, 4.7% . 5-8
Dibenzanthacene . 2/6 . 13, 16 . 4/21 . 5, 6, 6, 7 . 14/73 19% . 4-12 . 7/79, 9% 4-7
Methylcholan-
threne . 0/2 . - . 2/29 . 6, 7 . 19/59, 32% . 4-10 . 10/77, 13% . 3-5
9:10-DiInethyl-
1:2-benzanthracene 1/3 . 12 . 1/9 . 5 . 0/48 . . 9/83, 11% . 3-7TYPES OF TUMOURS IN LUNGS OF MICE1
Pulmonary adenoma.
It is clear from Table II that macroscopic adenomas of the right lung, the
site of the injection, were observed following injection of benzpyrene in only 2
out of 20 mice aged 15 and 17 months, following injection ofdibenzanthracene in
2 out of 6 mice aged 13 and 16 months, and following injection of 9:10-dimethyl-
1:2-benzanthracene in 1 out of 3 mice aged 12 months. The effective total is
the number of mice living to be as old as the youngest tumour-bearing mouse,
namely, 12 months.
In the sections prepared for the study ofthe spindle-cell sarcomas and thymic
tumours, small adenomas were observed in a few mice. As shown in Table II,
this phenomenon'occurred following injection of dibenzanthracene in 4 out of
21 mice aged 5-7 months, following injection of methylcholanthrene in 2 out of
29 mice aged 6 and 7 months, and followinginjection of 9:10-dimethyl-1:2-benzan-
thracene in 1 out of 9 mice aged 5 months. These figures apply only to the
adenomas, one, or at most two or three, in each mouse, observed in one section
through the lungs. Nothing is known about microscopically visible adenomas in
the remaining part of the lungs'. Neither is it known whether a corresponding
production of adenomas had taken place in the mice showing no grossly visible
tumours, but it is considered probable. It is worth mentioning that untreated
Street mice do not usually exhibit microscopic adenomas. Serial sections from
48 mice, ranging in age from four to twelve months (Rask-Nielsen, 1948), showed
oneadenoma, onlymicroscopicallyvisible, inamouseaged 12months. Thepresent
experiments, therefore, appear to indicate that 9:10-dimethyl-1:2-benzanthracene,
methylcholanthrene, and dibenzanthracene, and presumably also benzpyrene,
have induced pulmonary adenomas. The explanation why these growths were
in most cases visible only upon microscopic examination is probably afforded by
the short survival time of the mice (Table I). Although the experiments allow
of but an estimate of the development of pulmonary adenoma, they appear to
indicate that injection of dibenzanthracene has induced a more marked increase
in the development of adenoma than did injection of benzpyrene, methyl-
cholanthracene and 9:10-dimethyl-1:2-benzanthracene.
The macroscopic adenomas as well as those visible only upon microscopic
examination were of the ordinary, typical sub-pleural variety.
In addition to the adenomas of the right lung, adenomas were also present in
the left lung of a 7-month-old mouse injected with dibenzanthracene and in the
two 12-month-old mice injected with 9:10-dimethyl-1:2-benzanthracene. A
5-month-old mouse, injected with 9:10-dimethyl-1:2-benzanthracene, exhibited
adenomas only in the left lung. In this case the growths co-existed with a thymic
tumour. It is debatable whether these adenomas ofthe left lung are to be inter-
preted as spontaneous growths or induced by the carcinogenic action.
Spindle-cell sarcomas.
In about halfthe instances, the growths were circumscribed, spherical swellings
in thepulmonary tissue, and inthe remaining casesthe growth formed an adhesion
between the right lung and the diaphragm, the chest wall or the inferior medias-
tinum. In these latter cases the tumours have probably developed along the
entire path of the injection. All the growths were typical, ordinary spindle-cell
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sarcomas of varying differentiation. In two mice the spindle-cell sarcomas were
associated with lymphosarcomatous thymic tumours.
Table II shows that spindle-cell sarcomas were observed following injection
ofbenzpyrene in 2 out of 81 (2-5 per cent), following injection ofdibenzanthracene
in 14 out of 73 (19 per cent), and following injection of methylcholanthrene in
19 out of 59 mice (32 per cent), the effective total ofexperimental mice being the
number of mice living to be as old as the youngest tumour-bearing mouse of all
4 groups, namely four months. As mentioned above, spindle-cell sarcomas were
not observed following injection of 9:10-dimethyl-1:2-benzanthracene.
The minimum, maximum and average latent period of the growths, the inter-
val from injection until death, is set out in Table III. It will be seen that the
TABLE III.-Minimuim, Maximum and Average Latent Period (in weeks).
Spindle-cell sarcoma. Thymic tumours. Injection of 0 5 mg. A ^ .
gMinimum. Maximum. Average. Minimum. Maximum. Average.
Benzpyrene . . . . . 25 . 28 . 26 . 14 . 25 . 20
Dibenzanthracene . . . . 13 . 45 . 23 . 12 . 24 . 16
Methylcholanthrene . . . . 7 . 32 . 16 . 7 . 13 . 10
9:10-Dimethyl--1:2-benzanthracene . - . - . . 9 . 27 . 16
average latent period of spindle-cell sarcoma following injection of benzpyrene,
dibenzanthracene and methylcholanthrene was 26, 23 and 16 weeks respectively.
Thus, the experiments showed that the carcinogenicity of benzpyrene, diben-
zanthracene, and methylcholanthrene, injected in doses of 0-5 mg., for the inter-
stitial tissue of the lung increased in the order mentioned, and that the latent
period of the growths decreased in the same order, whereas 9:10-dimethyl-1:2-
benzanthracene-injected in the same dose-proved to be non-carcinogenic for
the interstitial tissue of the lung.
Thymic tumours.
It will be seen from Table II that thymic tumours were observed following
injection of benzpyrene into the lungs of 4 out of 85 (4.7 per cent), following
injection of dibenzanthracene in 7 out of 79 (9 per cent), following injection of
methylcholanthrene in 10, out of 77 (13 per cent) and following injection of
9:10-dimethyl-1:2-benzanthracene in 9 out of 83 mice (11 per cent). The effective
total of experimental mice was calculated on the basis of the number of mice
living to be as old as the youngest mouse exhibiting a thymic tumour within all
four groups, namely three months. With the exception of one spindle-cell
sarcoma of the thymus, observed in a mouse injected with methylcholanthrene,
all the growths were typical lymphosarcomas, made up of stem cells and accom-
panied by a frequently highly pronounced perivascular infiltration, particularly
in the central areas of the lungs. One mouse injected with 9:10-dimethyl-1:2-
benzanthracene exhibited such violent infiltration without actual thymic tumour.
The latent period of thymic tumours is given in Table III, which shows that
the average latent period following injection of benzpyrene, dibenzanthracene,
methylcholanthrene, and 9:10-dimethyl-1:2-benzanthracene was 20, 16, 10 and
16 weeks respectively.
The experiments revealed that the carcinogenicity of the hydrocarbons used,
in doses of 0-5 mg. introduced into the lung, for the thymus increased in theTYPES O TUMOURS IN LUNGS OF MICE
order benzpyrene, dibenzanthracene, 9:10-dimethyl-1:2-benzanthracene, and
methylcholanthrene and that the latent period decreased in the same order.
In addition to the local tumours, four cases of generalized leukaemia in mice
aged 13 to 20 months, occurred among the 20 mice living to be 13 months of age
in the benzpyrene group and one case of generalized leukaemia in a mouse aged
7 months among the 32 mice living to be at least 7 months ofage in the dibenzan-
thracene group. Presumably these cases are to be interpreted as spontaneous
phenomena, although it cannot be excluded that they may have been the result
of secondary invasion of the various organs by malignant cells induced in the
thymus by the carcinogenic action. The likelihood of such a pathogenesis of
stem cell leukaemia in Street mice has been advanced previously (Rask-Nielsen,
1948). None of the six cases of generalized leukaemia was affected with thymic
tumour.
On the whole, the experiments showed that the order of carcinogenicity of
the four hydrocarbons, as estimated from the incidence of tumours induced,
varied, when 0 5 mg. ofthe hydrocarbons was applied to the lungs of Street mice,
for the different tissues subject to their action. In the case of the specific lung
tissue, the carcinogenicity of dibenzanthracene proved higher than that of the
other three hydrocarbons; in the case of the interstitial tissue of the lungs, the
carcinogenicity decreased in the order: methylcholanthrene, dibenzanthracene,
benzpyrene to 9:10-dimethyl-1:2-benzanthracene which proved to be non-car-
cinogenic for this tissue; in the case of thymic tissue, the order was methyl-
cholanthrene, 9:10-dimethyl-1:2-benzanthracene, dibenzanthracene, benzpyrene.
The duration ofthe latent period was reversely proportional to the carcinogenicity.
DISCUSSION.
Attempts at inducing tumours in the lung by direct application ofcarcinogenic
hydrocarbons have been reported by a few earlier authors. According to these
reports, direct injection of methylcholanthrene (Esmarch, 1940a, 1940b, 1942)
produced almost exclusively spindle-cell sarcomas, whereas insertion of threads
coated with dibenzanthracene into the lung (Andervont, 1937a), intratracheal
administration of dibenzanthracene or methyloholanthrene (Shimlkin, 1939) or
tube feeding with dibenzanthracene (Magnus, 1939) produced practically only
pulmonary adenomas. Moreover, intravenous injection of dibenzanthracene or
methylcholanthrene, especially into strain A mice (Andervont and Lorenz, 1937;
Andervont, 1939a; Shimkin, 1940; Shimkin and Lorenz, 1942), and also into
mice of other strains (Andervont, 1939b) has been found to produce pulmonary
adenomas. This effect has also been reported following subcutaneous injection
of carcinogenic hydrocarbons (Andervont, 1937b, 1938). It appears that not
only the choice of hydrocarbon, but also the method of application and the
genetic constitution of the strain used have influenced the type and extent of
the tumour induction.
As regards the potency ofmethylcholanthrene to induce spindle-cell sarcomas
following direct injection into the lung and the special potency of dibenzanthra-
cene to induce pulmonary adenomas, the experiments reported in this paper
accord with the experience of previous authors. On the other hand, the power
of methylcholanthrene to induce pulmonary adenomas following intravenous
injection was not observed following direct injection of the hydrocarbon into the
lung.
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The present experiinents are in conformity with recently published studies
on the susceptibility of lung tissue to the small dose of 0-02 mg. of the same four
hydrocarbons (Rask-Nielsen, 1950a) which showed that the lung tissue of Street
mice was susceptible to this dose of dibenzanthracene, less so to this dose of
9:10-dimethyl-1:2-benzanthracene, but failed to respond to benzpyrene and
iiethylcholanthrene.
These recent experiments also showed that the thymus was particularly
susceptible to direct application of 0-02 mg. of 9:10-dimethyl-1:2-benzanthracene
and methylcholanthrene, less to the same dose of dibenzanthracene and least to
the same dose of benzpyrene. The incidence of thymic tumours induced by the
four hydrocarbons was therefore decreasing in the same order following injection
of a small dose into the thymus (Rask-Nielsen, 1950a) and a large dose into the
lung. The results cannot be compared with earlier experiments, since thymic
tumours following a direct carcinogenic action on the lung or thymus have not
been reported before, with the exception of a few instances of thymic lymupho-
sarcoma observed after injection of methylcholanthrene into the lung (Esmarch,
1940b).
It is evident that the carcinogenicity of 9:10-dimethyl-1:2-benzanthracene for
the interstitial connective tissue of the lungs differed from that of the other three
hydrocarbons. 9:10-Dimethyl-1:2-benzanthracene proved to be non-carcino-
genic for this tissue, whereas the carcinogenicity of the other three hydrocarbons
increased in the same order as their carcinogenicity for the subcutaneous connec-
tive tissue following application of the same dose into this tissue (Rask-Nielsen,
19501), i.e. in the order benzpyrene, dibenzanthracene, methylcholanthrene. Since 9:10-dimnethyl-1:2-benzanthracene has proved to have a carcinogenic effect,
though only rather slight, on the subcutaneous connective tissue (Rask-Nielsen,
1948, 1950b), the response of connective tissue to this hydrocarbon seems to vary
according to its site. The cause can hardly be a more rapid absorption of the
hydrocarbon from the lung than froin the subcutaneous tissue, since the result wzouild probably be a marked remote effect of the hydrocarbon, the development
of leukaemia, as seen following subcutaneous application (Rask-Nielsen, 1948,
1949). But such remote effect was not observed. Another explanation might
be given, namiely that 9:10-dimethyl-1:2-benzanthracene might be transformed
into non-carcinogenic substances at a rate which leaves time to affect the more
susceptible tissues, the specific lung tissue and the thymus (Rask-Nielsen, 1950a),
but niot the interstitial connective tissue which is less susceptible to '9:10-di-
mnethyl-1:2-benzanthracene. In that case, the other three hydrocarbons must
be presumed to be transformed into non-carcinogenic products at a slower rate
or to possess a higher carcinogenicity for the interstitial tissue of the lungs. Wrhen applied by the technique used in the present experiments, all four
hydrocarbons proved capable ofinducing specific tumours ofthe lung and thymlus.
9:10-Dimethyl-1:2-benzanthracene had a carcinogenic effect on the subcutaneous
connective tissue, but not on the connective tissue of the lung, whereas the other
three hydrocarbons proved carcinogenic for the subcutaneous connective tissue
as well as for that of the lung. It will be seen, therefore, that the four hydro-
carbons differed, not only as regards their relative carcinogenicity for the three
tunmour-producing tissues, but also as regards the order of this carcinogenicity
for the three tissues. These findings accord with the results of corresponding
experiments with small doses of hydrocarbon (Rask-Nielsen, 1950a) and show,
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like the latter, not only that (1) various tissues in the same strain and even in the
same mouse differ in their response to a given hydrocarbon, but also that (2)
there is a difference in the response of each tissue to the same dose by weight of
various hydrocarbons.
SUMMARY.
The object of the experiments reported in this paper was to study the car-
cinogenic potency of benzpyrene, dibenzanthracene, methylcholanthrene, and
9:10-dimethyl-1:2-benzanthracene, when injected directly into the lungs of Street
mice in large doses of 0-5 mg.
Dibenzanthracene appeared to produce a higher increase in the development
of pujlmonarv adenoma than did the other three hydrocarbons. Injections of
benzpyrene, dibenzanthracene, methylcholanthrene and 9:10-dimethvl-1:2-ben-
zanthracene were, moreover, followed bv spindle-cell sarcoma of the lung, and,
in a certain number of cases, spindle-cell sarcoma of the chest wall, diaphragm
or mediastinum and lymphosarcomatous thymic growths.
In a discussion of the results it is pointed out that the carcinogenicity of the
hydrocarbons for the three tumour-producing tissues differed and that the order
oftheir relative carcinogenicity for the three tissues also differed.
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